Evidence map›Paper›PMID 37671180›Full record

ArticleACS catalysis2023

Robust and General Late-Stage Methylation of Aryl Chlorides: Application to Isotopic Labeling of Drug-like Scaffolds.

Elliot Davenport, Daniela E Negru, Geoff Badman, David M Lindsay, William J Kerr

Abstract read
In one paragraph

Article in ACS catalysis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elliot DavenportDrug Substance Development, GSK, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, U.K.
Daniela E NegruDrug Substance Development, GSK, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, U.K.
Geoff BadmanDrug Substance Development, GSK, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, U.K.
David M LindsayDepartment of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XL, U.K.ORCID https://orcid.org/0000-0003-4498-5094
William J KerrDepartment of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XL, U.K.ORCID https://orcid.org/0000-0002-1332-785X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The preparation of isotopically labeled compounds for drug discovery and development presents a unique challenge. Both stable and radioactive isotopes must be incorporated into complex bioactive molecules as efficiently as possible, using precious, and often expensive, isotopically enriched reagents. Due to the ubiquity and importance of methyl groups in drug molecules, there is a requirement for a general, late-stage methylation that allows for the incorporation of both carbon and hydrogen isotopes. Herein, we report a highly efficient, robust palladium-catalyzed approach, optimized via high-throughput experimentation, for the methylation of aryl chlorides using potassium methyltrifluoroborate. A practically straightforward route to isotopically labeled methylating agents has also been developed, and the methodology applied to isotopologue synthesis, including the installation of isotopic labels in a range of drug-like scaffolds.

Identifiers

PMID37671180
PMCPMC10476154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.